NextMeds review
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
NextMeds at a glance
- Semaglutide
- $79/mo, same price at every dose
- Tirzepatide
- $119/mo, same price at every dose
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored NextMeds
Each score comes out of NextMeds's published pricing, disclosures and oversight, and the six combine into the 50/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- nextmeds.com
$79 and $119, flat at every dose, and every per-month figure reconciles exactly against its period total — a small thing many sellers here get wrong. The 'Was $199' anchor beside them is a retired offer's renewal price, a rate this offer has never charged anyone.
What to expect when you sign up
We walked NextMeds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on nextmeds.com (https://www.nextmeds.com/consultation?offer=offer_v9_tm)
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injection, month to monthThe standing rate, and the renewal rate — declared as the same object as the joining price in the live offer's own checkout data. |
| Compounded semaglutide | $76 | Injection, 3-month plan$228 for the period. |
| Compounded semaglutide | $73 | Injection, 6-month plan$438 for the period. |
| Compounded semaglutide | $49 | Injection, 12-month plan$588 for the period. This is the figure the homepage advertises as its starting price. |
| Compounded tirzepatide | $119 | Injection, month to monthThe standing rate, and the renewal rate. |
| Compounded tirzepatide | $115 | Injection, 3-month plan$345 for the period. |
| Compounded tirzepatide | $110 | Injection, 6-month plan$660 for the period. |
| Compounded tirzepatide | $99 | Injection, 12-month plan$1,188 for the period. This is the second figure the homepage advertises. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from NextMeds's public disclosures at last review and change often; confirm the current number on NextMeds's own site.
What we like
- The renewal price is the same as the joining price on the live offer, confirmed in its own checkout data rather than from marketing copy
- Genuinely flat: the same rate at every dose on both molecules
- $79 month-to-month for semaglutide is among the lowest standing rates on this roster
- Every advertised per-month figure reconciles exactly against its period total ($228 over three months is $76, $588 over twelve is $49)
- Names two compounding pharmacies outright, with phone numbers — The Pharmacy Hub and Foothills Pharmacy
- Names its clinical group, OpenLoop Healthcare Partners, PC
- A full refund is available if a provider finds you medically ineligible
- Ships to all 50 states by its own FAQ
The caveats
- ⚠ Operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds — four consumer brands from one company rather than four independent options
- ⚠ That operator carries an FDA warning letter: issued 8 June 2026 to Trinity HealthCare Supply, LLC dba altRx, MARCS-CMS 728236, for false and misleading claims and misbranding in telehealth, with no close-out recorded
- The advertised $49 and $99 are the twelve-month totals divided by twelve, printed under the words 'SAME PRICE EVERY MONTH'; the month-to-month rates are $79 and $119
- The 'Was $199' anchor beside them is the retired offer's renewal price, a rate this offer has never charged
- The countdown is not a deadline — it read 'ENDS AUGUST 15TH' and then 'AUGUST 20TH' within the same hour, and the offer's own stored end date is June 30th
- The 'Save $110' and 'Save $150' figures imply reference prices of $189 and $269, which do not match the $199 shown in the hero
- Your order becomes non-refundable as soon as you submit the intake, before a clinician has reviewed it
- Refund requests must be made in writing within 28 days of payment
- How many weeks of medication a charge buys is never stated — and its sibling brand Trinity Meds, on the same platform, defines its month as four weeks
- Nothing on the public site addresses pregnancy, breastfeeding, PCOS or menopause
- Compounded only, with no brand-name lane and no oral form
NextMeds for mothers: our verdict
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter. It runs about $79/month, flat across every dose — toward the affordable end of what we track.
We weigh NextMeds the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What NextMeds actually costs
- Compounded semaglutide — Injection, month to month: $79/mo
- Compounded semaglutide — Injection, 3-month plan: $76/mo
- Compounded semaglutide — Injection, 6-month plan: $73/mo
- Compounded semaglutide — Injection, 12-month plan: $49/mo
- Compounded tirzepatide — Injection, month to month: $119/mo
- Compounded tirzepatide — Injection, 3-month plan: $115/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications NextMeds prescribes
NextMeds prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where NextMeds fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in NextMeds's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NextMeds is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a genuinely flat month-to-month rate and will ignore both the countdown and the twelve-month headline — and who knows they are not choosing independently of Lean Meds or Trinity Meds.
Alternatives to NextMeds
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing NextMeds
Head-to-head & alternatives
NextMeds, answered
- How much does NextMeds cost?
- When we last checked, the cheapest ongoing compounded price at NextMeds was around $79 a month: $79/mo, same price at every dose for semaglutide and $119/mo, same price at every dose for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is NextMeds safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to NextMeds as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does NextMeds offer both semaglutide and tirzepatide?
- Yes — NextMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does NextMeds rank for mothers?
- NextMeds takes 50/100 in our Editors' Rating, placing it #191. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect NextMeds's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.